Latest Reports

The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking. 

It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations. 

This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment. 

The “2026 IOL Market Report” delivers a comprehensive, data-driven view of the global intraocular lens market, combining detailed analysis of today’s landscape with five-year forecasts designed to inform strategy, investment, and competitive positioning. 

Built on Market Scope’s proprietary models and deep industry insight, the report identifies the trends shaping demand, tracks shifts in technology adoption, and highlights the factors that will define success in an increasingly competitive and innovation-driven market. 

The analysis segments the market across 11 distinct IOL categories—commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs— to provide a clear view of where growth is occurring and how the premium market continues to evolve. 

In addition, the report profiles 40 leading companies, offering insight into their product portfolios, strategic positioning, competitive strengths, and future outlook to provide you with the intelligence needed to benchmark competitors and identify opportunities in the global IOL market. 

The 2026 Refractive Surgery Market Report delivers an in-depth look at the global refractive and presbyopia-correcting surgery market, providing the data and insight needed to understand where the market is headed and where new opportunities are emerging. 

The report examines LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and emerging refractive and presbyopia-correcting technologies, tracking the trends, innovations, and competitive forces expected to shape the market over the next five years. 

Analysis covers the full refractive surgery landscape, from patient demographics and procedure volumes to surgeons, laser centers, and manufacturers of excimer and femtosecond lasers, diagnostic equipment, phakic IOLs, and other refractive technologies. 

With detailed unit and revenue forecasts, market share analysis, and profiles of 15 leading competitors, the report provides a clear view of market growth, technology adoption, competitive positioning, and the companies and innovations driving the next phase of refractive surgery. 

Market Scope’s "2026 Retinal Disease Model" delivers deep, country-level insight into the true scale of retinal disease worldwide, with detailed prevalence estimates and five-year forecasts by age group for every country with a population over one million.

Built on the latest clinical research and global demographic projections, this proprietary model provides a rigorous, forward-looking view of retinal disease—and can be customized by geography and disease category to match specific strategic needs. The model enables companies to quantify addressable patient populations, evaluate target markets for clinical- and commercial-stage products, and understand how disease volume and demographics are expected to evolve over time.

Market Scope’s "2026 Glaucoma Disease Model" offers extensive country-level prevalence data and five-year forecasts for glaucoma by type and by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Market Scope’s “2026 Ophthalmic Diagnostic Equipment Market Report” provides a comprehensive view of the global market for ophthalmic diagnostic technologies. The report examines current markets for diagnostic equipment used in ophthalmic surgery, refracting and screening instruments, and emerging technologies. It also includes five-year global forecasts and detailed regional and economic analysis across the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and developing markets worldwide. 

The report evaluates more than 800 devices from 115 manufacturers, spanning a broad range of technologies, including corneal topographers, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and advanced microscopy systems. 

Dedicated sections for each equipment category provide detailed market sizing, pricing trends, competitor market share, installed equipment base, and company profiles. Together, these insights give manufacturers, investors, and eye care providers a clear picture of the competitive landscape, where the market is headed, and the technologies and opportunities likely to shape ophthalmic diagnostics over the next five years. 

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

The “2026 Ophthalmic OR Microscopes Market Report” provides a focused look at the global market for ophthalmic operating room microscopes. A companion to Market Scope’s “2026 Ophthalmic Diagnostic Equipment Market Report,” it helps manufacturers and investors assess market trends, growth opportunities, and competitive performance. 

The report breaks the market into basic, standard, and advanced microscopes, with estimates of unit sales, installed base, and average selling prices for each segment. Profiles of leading manufacturers add context on the competitive landscape and help readers see how their position compares. 

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

The “2026 Glaucoma Surgical Device Market Report” provides a comprehensive analysis of the global glaucoma surgical device market, examining the technologies, clinical trends, competitive landscape, and market forces shaping the future of glaucoma surgery across every major region.

The report explores global glaucoma prevalence, treatment patterns, and the continued evolution of surgical care. It provides in-depth coverage of commercially available devices—including trabecular meshwork (TM) bypass stents, subconjunctival shunts, canal surgery devices, suprachoroidal devices, and tube shunts—while also assessing emerging technologies and investigational products expected to influence future treatment strategies and market growth.

Detailed market forecasts through 2031 provide unit and revenue projections across major device categories, procedure types, and geographic markets. The report also features competitive market share analysis, adoption trends, and comprehensive profiles of leading manufacturers and emerging innovators, providing a clear view of the companies and technologies driving the next phase of the glaucoma surgical device market.